Published 25 days ago • loading... • Updated 23 days ago

US drug lobby group names former House leader Cantor as CEO

On Tuesday, the Pharmaceutical Research and Manufacturers of America named former United States House Majority Leader Eric Cantor as its next president and chief executive officer, effective November 9.
Cantor, who served as House Majority Leader from 2011 to 2014, brings experience from his recent role as vice chairman and managing director at Moelis & Company after departing Congress.
During his congressional tenure, Cantor helped pass the 21st Century Cures Act, which provided significant funding for the National Institutes of Health and included Food and Drug Administration reforms designed to speed medicine approvals.
He succeeds CEO Stephen Ubl, who led PhRMA since 2015 during a period when the pharmaceutical industry faced intense pressure from lawmakers and United States administrations over prescription drug pricing, market access, and regulation.
Consumer watchdog Public Citizen criticized the appointment, calling Cantor an "experienced reverse Robin Hood," while PhRMA spent a record $38 million on lobbying to counter legislative pressure on drug prices.

Insights by Ground AI

26 Articles

Conservative Review

Right

Why Eric Cantor Going To Head Big Pharma Is The Swampiest Move Ever

Eric Cantor will become the next head of PhRMA, and the two seem made for each other for all the wrong reasons.

23 days ago·Houston, United States

Read Full Article

The Federalist

Right

Why Eric Cantor Going To Head Big Pharma Is Super Swampy

Eric Cantor will become the next head of PhRMA, and the two seem made for each other for all the wrong reasons.

23 days ago·Chicago, United States

Read Full Article

Seeking Alpha

Lean Right

Pharmaceutical industry lobbying group names new CEO, Eric Cantor

PhRMA names ex-House Majority Leader Eric Cantor as its next CEO. Read more here.

25 days ago·Ra'anana, Israel

Read Full Article

biopharmadive.com

Center

PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval

A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.

25 days ago

Read Full Article

Pharmaphorum

Center

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.

25 days ago

Read Full Article

voz.us

Right

A Former Republican Congressional Leader Is Named President of PhRMA, Washington DC's Powerful Pharmaceutical Lobby

Eric Cantor, former Republican leader of the House of Representatives, was elected as the next president and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA), one of the leading lobby organizations in the pharmaceutical industry in the United States. Cantor will take office on November 9 and replace Stephen Ubl, who has been running the organization since 2015. Cantor, 63, was a member of the House of Representatives between 2…

25 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year